Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1999 1
2004 2
2006 2
2007 1
2009 1
2010 3
2011 5
2012 2
2013 4
2014 4
2015 4
2016 3
2017 5
2018 6
2019 5
2020 5
2021 9
2022 5
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Maturi RK, et al. JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029. JAMA. 2023. PMID: 36749332 Free PMC article.
IMPORTANCE: Anti-vascular endothelial growth factor (VEGF) injections in eyes with nonproliferative diabetic retinopathy (NPDR) without center-involved diabetic macular edema (CI-DME) reduce development of vision-threatening complications from diabetes over at least 2 years, but …
IMPORTANCE: Anti-vascular endothelial growth factor (VEGF) injections in eyes with nonproliferative diabetic retinopathy (NPDR) without cent …
KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation.
Cif L, Demailly D, Lin JP, Barwick KE, Sa M, Abela L, Malhotra S, Chong WK, Steel D, Sanchis-Juan A, Ngoh A, Trump N, Meyer E, Vasques X, Rankin J, Allain MW, Applegate CD, Attaripour Isfahani S, Baleine J, Balint B, Bassetti JA, Baple EL, Bhatia KP, Blanchet C, Burglen L, Cambonie G, Seng EC, Bastaraud SC, Cyprien F, Coubes C, d'Hardemare V; Deciphering Developmental Disorders Study; Doja A, Dorison N, Doummar D, Dy-Hollins ME, Farrelly E, Fitzpatrick DR, Fearon C, Fieg EL, Fogel BL, Forman EB, Fox RG; Genomics England Research Consortium; Gahl WA, Galosi S, Gonzalez V, Graves TD, Gregory A, Hallett M, Hasegawa H, Hayflick SJ, Hamosh A, Hully M, Jansen S, Jeong SY, Krier JB, Krystal S, Kumar KR, Laurencin C, Lee H, Lesca G, François LL, Lynch T, Mahant N, Martinez-Agosto JA, Milesi C, Mills KA, Mondain M, Morales-Briceno H; NIHR BioResource; Ostergaard JR, Pal S, Pallais JC, Pavillard F, Perrigault PF, Petersen AK, Polo G, Poulen G, Rinne T, Roujeau T, Rogers C, Roubertie A, Sahagian M, Schaefer E, Selim L, Selway R, Sharma N, Signer R, Soldatos AG, Stevenson DA, Stewart F, Tchan M; Undiagnosed Diseases Network; Verma IC, de Vries BBA, Wilson JL, Wong DA, Zaitoun R, Zhen D… See abstract for full author list ➔ Cif L, et al. Among authors: gonzalez v. Brain. 2020 Dec 5;143(11):3242-3261. doi: 10.1093/brain/awaa304. Brain. 2020. PMID: 33150406 Free PMC article.
At 1 year post-deep brain stimulation, >50% of subjects showed BFMDRS-M and BFMDRS-D improvements of >30%. In the long-term deep brain stimulation cohort (deep brain stimulation inserted for >5 years, n = 8), improvement of >30% was maintained in 5/8 and 3/8 su …
At 1 year post-deep brain stimulation, >50% of subjects showed BFMDRS-M and BFMDRS-D improvements of >30%. In the long-term dee …
Long-term stability of clinical-grade lentiviral vectors for cell therapy.
Jadlowsky JK, Leskowitz R, McKenna S, Karar J, Ma Y, Dai A, Plesa G, Chen F, Alexander K, Petrella J, Gong N, Hwang WT, Farrelly O, Barber-Rotenberg J, Christensen S, Gonzalez VE, Chew A, Fraietta JA, June CH. Jadlowsky JK, et al. Among authors: gonzalez ve. Mol Ther Methods Clin Dev. 2024 Jan 10;32(1):101186. doi: 10.1016/j.omtm.2024.101186. eCollection 2024 Mar 14. Mol Ther Methods Clin Dev. 2024. PMID: 38282894 Free PMC article.
Although existing data increasingly support the usefulness and safety of clinical-grade lentiviral vectors used in cell manufacturing, comprehensive studies specifically addressing their long-term stability are currently lacking. This is significant considering the high co …
Although existing data increasingly support the usefulness and safety of clinical-grade lentiviral vectors used in cell manufacturing, compr …
Role of Radiation Therapy in the Treatment of Hodgkin Lymphoma.
Gonzalez VJ. Gonzalez VJ. Curr Hematol Malig Rep. 2017 Jun;12(3):244-250. doi: 10.1007/s11899-017-0385-y. Curr Hematol Malig Rep. 2017. PMID: 28497317 Review.
With improved efficacy of systemic therapy and the ever-increasing recognition of treatment-related morbidity in long-term survivors, the role of radiotherapy has evolved significantly. Modern combined modality therapy (CMT) with multi-agent chemotherapy followed by involv …
With improved efficacy of systemic therapy and the ever-increasing recognition of treatment-related morbidity in long-term survivors, …
Evaluation of Clinical Tools to Screen and Assess for Obstructive Sleep Apnea.
Gamaldo C, Buenaver L, Chernyshev O, Derose S, Mehra R, Vana K, Walia HK, Gonzalez V, Gurubhagavatula I; OSA Assessment Tools Task Force of the American Academy of Sleep Medicine. Gamaldo C, et al. Among authors: gonzalez v. J Clin Sleep Med. 2018 Jul 15;14(7):1239-1244. doi: 10.5664/jcsm.7232. J Clin Sleep Med. 2018. PMID: 29991434 Free PMC article.
Obstructive sleep apnea (OSA) is a globally recognized medical condition, associated with development of long-term adverse health consequences, including cardiovascular disease, cerebrovascular disease, neurocognitive deficiencies, and vehicular and occupational accidents. …
Obstructive sleep apnea (OSA) is a globally recognized medical condition, associated with development of long-term adverse health con …
Early intervention model of inpatient diabetes care improves glycemia following hospitalization.
Kyi M, Colman P, Gonzalez V, Hall C, Cheuk N, Fourlanos S. Kyi M, et al. Among authors: gonzalez v. J Hosp Med. 2023 Apr;18(4):337-341. doi: 10.1002/jhm.13057. Epub 2023 Feb 4. J Hosp Med. 2023. PMID: 36739111 Clinical Trial.
Admission to hospital provides an opportunity to optimize long-term diabetes management, but clinical inertia is common. We previously reported the randomized study of a proactive inpatient diabetes service (RAPIDS), investigating an early intervention model of care and de …
Admission to hospital provides an opportunity to optimize long-term diabetes management, but clinical inertia is common. We previousl …
Hybrid Fluorescent Mass-Tag Nanotrackers as Universal Reagents for Long-Term Live-Cell Barcoding.
Delgado-Gonzalez A, Laz-Ruiz JA, Cano-Cortes MV, Huang YW, Gonzalez VD, Diaz-Mochon JJ, Fantl WJ, Sanchez-Martin RM. Delgado-Gonzalez A, et al. Among authors: gonzalez vd. Anal Chem. 2022 Aug 2;94(30):10626-10635. doi: 10.1021/acs.analchem.2c00795. Epub 2022 Jul 22. Anal Chem. 2022. PMID: 35866879 Free PMC article.
Barcode reagents currently used label intracellular proteins in fixed and permeabilized cells and, therefore, are not suitable for studies with live cells in long-term culture prior to analysis. In this study, we report the development of fluorescent palladium-based hybrid …
Barcode reagents currently used label intracellular proteins in fixed and permeabilized cells and, therefore, are not suitable for studies w …
Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis.
Chitnis T, Tenembaum S, Banwell B, Krupp L, Pohl D, Rostasy K, Yeh EA, Bykova O, Wassmer E, Tardieu M, Kornberg A, Ghezzi A; International Pediatric Multiple Sclerosis Study Group. Chitnis T, et al. Mult Scler. 2012 Jan;18(1):116-27. doi: 10.1177/1352458511430704. Epub 2011 Dec 6. Mult Scler. 2012. PMID: 22146610
Mechanisms for conducting high-impact, multicenter studies, including long-term follow-up in pediatric MS, are required to ensure that all MS patients, irrespective of age, benefit from advances in MS therapeutics....
Mechanisms for conducting high-impact, multicenter studies, including long-term follow-up in pediatric MS, are required to ensure tha …
Bees display limited acclimation capacity for heat tolerance.
Gonzalez VH, Herbison N, Robles Perez G, Panganiban T, Haefner L, Tscheulin T, Petanidou T, Hranitz J. Gonzalez VH, et al. Biol Open. 2024 Mar 1;13(3):bio060179. doi: 10.1242/bio.060179. Epub 2024 Mar 19. Biol Open. 2024. PMID: 38427330 Free PMC article.
We measured the response of the critical thermal maximum (CTMax) to short-term acclimation in foragers of six bee species from the Greek island of Lesvos, which differ in body size, nesting habit, and level of sociality. ...
We measured the response of the critical thermal maximum (CTMax) to short-term acclimation in foragers of six bee species from the Gr …
Long-term safety of the tafenoquine antimalarial chemoprophylaxis regimen: A 12-month, randomized, double-blind, placebo-controlled trial.
Novitt-Moreno A, Martidis A, Gonzalez V, Ransom J, Scott CB, Dow G, Reid M, Smith B, Zottig VE, Read LT, Garver Baldwin LS, Chen FK. Novitt-Moreno A, et al. Among authors: gonzalez v. Travel Med Infect Dis. 2022 Jan-Feb;45:102211. doi: 10.1016/j.tmaid.2021.102211. Epub 2021 Nov 18. Travel Med Infect Dis. 2022. PMID: 34801714 Free article. Clinical Trial.
BACKGROUND: Tafenoquine is a long-acting 8-aminoquinoline approved for antimalarial prophylaxis for 6 months. Additional data is needed to establish the drug's longer-term safety profile, including potential ophthalmic or neuropsychiatric effects. ...
BACKGROUND: Tafenoquine is a long-acting 8-aminoquinoline approved for antimalarial prophylaxis for 6 months. Additional data is needed to e …
65 results